Eularis Updates Reports That Help Pharmaceutical Companies Do More for Real Growth Than Simply Downsizing
LONDON, U.K. (SEND2PRESS NEWSWIRE) — The pharmaceutical industry is facing unprecedented challenges on many fronts – a slew of patient expiries, a lack of blockbusters in the pipeline to replace the patent expiries, decreasing growth in many major markets, generic competition, constantly changing regulatory and competitive environment rendering old tools for analysis obsolete, increased pressure on CEOs to deliver shareholder growth resulting in budget cuts, downsizing, and less than optimal results.